| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |